Life Science Compliance Update

March

2016

The Black Hole – AMP as Viewed from A Pharmaceutical Manufacturer’s Compliance Office

Written by , Posted in Pricing

By: Chris Cobourn, Managing Director, Huron Life Sciences

The Centers for Medicare and Medicaid Services (“CMS”) have finally promulgated the final rule on Covered Outpatient Drugs including the Average Medicaid Price (AMP) calculation. This article explores what pharmaceutical compliance offices need to know to help their organizations mitigate the risks from not understanding the new provisions.


   or   

Topic tags:

Menu Title